Literature DB >> 35278833

The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction.

Shiyu Hu1, Yang Gao1, Rifeng Gao2, Yiwen Wang1, Yanan Qu1, Ji'e Yang1, Xiang Wei2, Feng Zhang3, Junbo Ge4.   

Abstract

BACKGROUND: During myocardial infarction (MI), the stimulation of the cGAS-STING-IRF3 pathway in infiltrated macrophages can induce the apoptosis of cardiomyocytes and the fibrosis of cardiac fibroblasts, while H-151 is reported as a selective STING inhibitor. We intended to use H-151 to alleviate MI injury.
METHODS: Male C57BL/6J mice were subjected to induce MI, while H-151 (750 nmol) were used for treatment. Myocardial function was assessed through echocardiology and cardiac fibrosis was evaluated by Masson's Trichrome-staining. The stimulation of the STING pathway and the aggravation of inflammation was assessed by levels of protein and mRNA. BMDMs were stimulated by dsDNA extracted from the murine heart, while H-151 was used as treatment. After co-culturing adult cardiomyocytes and cardiac fibroblasts with supernatant of BMDMs, the apoptosis of adult cardiomyocytes and the fibrosis of cardiac fibroblasts was assessed.
RESULTS: H-151 treatment showed significant function in preserving myocardial function and decreasing cardiac fibrosis 28 days after MI. H-151 treatment showed significant function in inhibiting the cGAS-STING-IRF3 pathway and inflammation, especially type I interferon response. H-151 could alleviate the type I interferon response in BMDMs elicited by cardiac dsDNA, and thus H-151 could attenuate the apoptosis of adult cardiomyocytes and fibrosis of cardiac fibroblasts after co-culturing them with the supernatant of BMDMs.
CONCLUSIONS: H-151, a selective inhibitor of the cGAS-STING-IRF3 pathway, can preserve myocardial function and alleviate cardiac fibrosis after MI by inhibiting the type I interferon response in infiltrated macrophages triggered by cardiac dsDNA which increase the apoptosis of adult cardiomyocytes and fibrosis of cardiac fibroblasts.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  H-151; Macrophages; Myocardial fibrosis; Myocardial infarction; STING

Mesh:

Substances:

Year:  2022        PMID: 35278833     DOI: 10.1016/j.intimp.2022.108658

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  H151, A SMALL MOLECULE INHIBITOR OF STING AS A NOVEL THERAPEUTIC IN INTESTINAL ISCHEMIA-REPERFUSION INJURY.

Authors:  Molly Kobritz; Timothy Borjas; Vihas Patel; Gene Coppa; Monowar Aziz; Ping Wang
Journal:  Shock       Date:  2022-07-30       Impact factor: 3.533

2.  Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis.

Authors:  Haimei Zeng; Ying Gao; Wenqiang Yu; Jiping Liu; Chaoqun Zhong; Xi Su; Shihong Wen; Hua Liang
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

Review 3.  Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect.

Authors:  Yao Du; Hui Zhang; Xiaoyan Nie; Yajun Qi; Shi Shi; Yingying Han; Wenchen Zhou; Chaoyong He; Lintao Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.